Form 4: Teladoc Health Executive Sells Shares Following RSU Vesting Under Pre-Arranged Plan

Fernando M. Rodrigues, President of BetterHelp at Teladoc Health, Inc., sold 6,532 shares of common stock in early June 2025, primarily to cover tax obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Fernando M. Rodrigues, President of BetterHelp, a segment of Teladoc Health, Inc. (TDOC), reported transactions involving the company's common stock.
• On May 30, 2025, Mr. Rodrigues acquired a total of 6,532 shares of Teladoc Health common stock through the conversion of restricted stock units (RSUs). This included 5,491 shares from a December 1, 2023 grant and 1,041 shares from a March 19, 2024 grant.
• On June 2, 2025, 2,358 shares were sold at a price of $6.86 per share to satisfy tax withholding obligations related to the vesting of RSU awards.
• On June 3, 2025, an additional 4,174 shares were sold at a price of $6.91 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted by Mr. Rodrigues on November 18, 2024, and amended on November 27, 2024.
• Following these transactions, Mr. Rodrigues' direct beneficial ownership of the common stock from these specific vested awards is reported as 0 shares, though he retains significant unvested RSU holdings (32,948 and 7,293 derivative securities).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it involves insider selling, the sales are primarily for tax purposes and under a pre-arranged 10b5-1 plan, which mitigates negative interpretations. The vesting of RSUs is a positive for the executive and reflects ongoing compensation.

Positives

• The vesting of 6,532 restricted stock units indicates the realization of executive compensation, aligning management's interests with shareholder value creation over time.
• The sale of shares was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic and pre-determined approach to stock sales rather than a reaction to immediate market conditions.

Negatives

• The disposition of 6,532 shares by a key executive, even if pre-planned and for tax purposes, represents a reduction in direct beneficial ownership of common stock from the vested awards.
• The sales occurred at prices of $6.86 and $6.91 per share, which may be perceived as low given the company's historical stock performance, though this is a factual observation of the transaction price.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide direct insights into broader industry trends within the telehealth or digital health sectors. It reflects an executive's compensation realization and planned stock sales, which are common practices across various industries.

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even if pre-planned, can sometimes be viewed with caution, though the specific reasons (tax withholding, 10b5-1 plan) reduce the likelihood of a negative interpretation. The executive still holds significant unvested RSUs, indicating continued alignment.
• Employees: The vesting and sale of RSUs are part of the company's compensation structure, which can be a positive for employee morale and retention if seen as fair and competitive.

Key Dates

Keywords

Teladoc Health, TDOC, Form 4, Insider Trading, Restricted Stock Units, RSU, Rule 10b5-1 Plan, Executive Compensation, Share Sale, Fernando M. Rodrigues, BetterHelp